Ozerov A A, Bagmetova V V, Chernysheva Yu V, Tyurenkov I N
Volgograd State Medical University, Ministry of Health of the Russian Federation, Volgograd, Russia.
Bull Exp Biol Med. 2016 Mar;160(5):649-52. doi: 10.1007/s10517-016-3240-6. Epub 2016 Mar 29.
A new (aryloxyalkyl)adenine derivative Adeprophen (9-[2-(4-isopropylphenoxy)ethyl]adenine, VMA-99-82) has a strong antidepressant effect on the model of reserpine-induced depression in rats (single dose 4 mg/kg, intraperitoneally). This effect manifested in suppression of depression-like behavior in the Porsolt forced swimming test (shortening of immobility time and increase in immobility latency, number of jumping episodes, and time of active swimming) and sucrose consumption/preference test (increase in the consumption of 20% sucrose solution in g/100 g body weight and percentage of sucrose preference in relation to the total fluid preference). Adeprophen had a greater antidepressant effect than sertraline and fluoxetine, but was less potent than amitriptyline, imipramine, venlafaxine, and to a lesser extent to paroxetine.
一种新型(芳氧基烷基)腺嘌呤衍生物阿地普芬(9-[2-(4-异丙基苯氧基)乙基]腺嘌呤,VMA-99-82)对大鼠利血平诱导的抑郁模型具有强效抗抑郁作用(单次腹腔注射剂量4mg/kg)。这种作用表现为在波索尔特强迫游泳试验中抑制抑郁样行为(缩短不动时间、增加不动潜伏期、跳跃次数和主动游泳时间)以及在蔗糖消耗/偏好试验中(增加20%蔗糖溶液的消耗,以g/100g体重计,以及相对于总液体偏好的蔗糖偏好百分比)。阿地普芬的抗抑郁作用强于舍曲林和氟西汀,但效力低于阿米替林、丙咪嗪、文拉法辛,对帕罗西汀的效力稍低。